Jong, D. de

(Daphne de Jong)

patient chemotherapy treatment lymphoma disease study i-chop group cycle response survival high-dose -21 hodgkin infection result blood caebv infection regimen trial cancer mantle cell lymphoma radiotherapy number toxicity protocol i-chop arm netherland outcome prognostic therapy high-dose ara-c ara-c dose intensity -21 arm table if-rt r-chop cyclophosphamide doxorubicin rituximab stage remission factor oncol caebv journal centre radiation epstein-barr virus infection cell rescue department relapse j clin oncol analysis aa-ipi signi virus cell transplantation erasmu randomized intensity oncology center ﬁcation autologou abnormality mantle ﬁ rst vincristine malignancy transplantation ff p ro epstein-barr france british journal death erasmus mc report course

4 Most Recent Publications

High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients (Article) Veer, M.B. van 't Jong, D. de MacKenzie, M. Kluin-Nelemans, H.C. Oers, M.H.J. van Zijlstra, J. Hagenbeek, A. Putten, W.L.J. van	2009-02-01
Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients (Article) Sonke, G.S. Ludwig, I. Oosten, H. van Baars, J.W. Meijer, E. Kater, A.P. Jong, D. de	2008-07-01
Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: A phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) (Article) Verdonck, L.F. Notenboom, A. Jong, D. de MacKenzie, M.A. Verhoef, G.E.G. Kramer, M.H.H. Ossenkoppele, G.J. Doorduijn, J.K. Sonneveld, P. Imhoff, G. van	2007-04-01
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma (Article) Aleman, B.M.P. Raemaekers, J. Lievens, Y. Jong, D. de Pinna, A. Henry-Amar, M. Tomiŝiĉ, R. Baaijens, M. Bortolus, R. Lybeert, M.L.M. Maazen, R.W. van der Girinsky, T. Demeestere, G. Lugtenburg, P.J.	2007-01-01

Message*:
Your Email Adress*:
	*: Required fields, please provide an email address so that the RePub team can contact you if needed.